NORDEA INVESTMENT MANAGEMENT AB
Position in CRL — Charles River Laboratories International, Inc.
CIK 1218210
STOCKHOLM, V7
Position in CRL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,681,045
-$1,229,313 QoQ
Shares Held
56,122
+2.6% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026NORDEA INVESTMENT MANAGEMENT AB holds $1,532,838,136 across 17 Diagnostics & Research names. CRL ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,779,019 | $337,302,001 | |
| 2 | LH |
Labcorp Holdings Inc.
|
1,045,142 | $278,854,336 | |
| 3 | A |
Agilent Technologies, Inc.
|
2,363,299 | $269,368,819 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
156,133 | $196,914,938 | |
| 5 | ILMN |
Illumina, Inc.
|
987,054 | $121,664,275 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
705,547 | $120,323,984 | |
| 7 | WAT |
Waters Corp /De/
|
266,828 | $79,461,377 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
113,462 | $54,483,316 |
All Filings in CRL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,681,045 | 56,122 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,910,358 | 54,694 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $5,957,683 | 38,078 | Shares | Defined | 2025-10-27 | |
| 2024-12-31 | $878,880 | 4,761 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $937,774 | 4,761 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $979,602 | 4,742 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,187,031 | 4,381 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,035,668 | 4,381 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $809,005 | 4,128 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $914,797 | 4,351 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $878,118 | 4,351 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $851,117 | 3,906 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $632,318 | 3,213 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $687,485 | 3,213 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $793,412 | 2,794 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $1,052,723 | 2,794 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,152,999 | 2,794 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,033,556 | 2,794 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $11,043,392 | 38,103 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,168,362 | 36,694 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $8,504,103 | 37,554 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $13,020,458 | 74,680 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,756,728 | 37,689 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||